Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism Research Group Advancing research in diabetes, obesity and metabolism
We study the metabolic causes of chronic disease while building an internationally recognized center for fundamental and translational research.
The studies
Diabetes, obesity, fatty liver disease, and atherosclerosis are among the most common, costly, and preventable of all health problems, and mainly due to dysregulation of lipid, glucose or energy metabolism. Metabolic dysregulation may cause a number of other chronic diseases and conditions. The researchers also aim to build a collaborative internationally-recognized Center of Excellence for fundamental and translational research in diabetes, obesity and metabolism.
A patient’s perspective on diabetes research
Dan shares his experiences living with diabetes, and his hopes for the future thanks to discoveries in research.
The statistics
30M+
More than 30 million people in the U.S. have diabetes.
No. 1
By 2030, non-alcoholic steatohepatitis will be the No. 1 reason for liver transplants in the U.S.
42.4%
Obesity prevalence in the United States in 2017-18, according to the CDC.
The successes
- Uncovered novel pathogenic mechanisms of NAFLD and atherosclerosis
- Identified novel targets for treatment of NAFLD, atherosclerosis, and obesity
- Identified novel mechanisms of bile acid regulation
The scientists
Researchers within this area have expertise in studying bile acid, glucose, lipid and lipoprotein metabolism.
- Marc Basson, M.D., Ph.D., M.B.A. Lab | Biography
- Jessica Ferrell, Ph.D. Lab | Biography
- Takhar Kasumov, Ph.D.
- Manabu Kurokawa, Ph.D. (Kent State University)
- Yoon-Kwang Lee, Ph.D
- Guiming Liu, M.D., Ph.D.
- Priya Raman, Ph.D.
- Xinwen Wang, Ph.D.
- Jaclyn Welles, Ph.D., Ignite Scholar
- Jianguo Wu, M.D., Ph.D.
Our research
Contact
Jessica Ferrell, Ph.D.
Assistant Professor of Biomedical Sciences
[email protected]
Phone: 330-325-6468
Office: F-242